Results 121 to 130 of about 16,160 (225)

Assessment of internal consistency reliability and concurrent validity of PROMIS^® Dyspnea Characteristics v1.0, PROMIS^® Dyspnea Functional Limitations 10a, and PROMIS^® Global Health v1.2 in a dysautonomia cohort. [PDF]

J Patient Rep Outcomes
Latham AJ, O'Dell JA, Ho T, Chavis S, Smith SE.   +4 more
europepmc   +1 more source

Short-Course, Low-Dose Metoclopramide as Bridge Therapy for Dysautonomia-Associated Gastrointestinal Dysmotility in Adolescents: A Case Series. [PDF]

Children (Basel)
Wilder A, Morris C, Patel D, Setya A.
europepmc   +1 more source

Extensive dysautonomia in early-stage multiple system atrophy reflects survival differences: insights from data-driven subtypes. [PDF]

J Neurol
Ha SH, Yang HJ, Lee S, Woo KA, Shin JH, Kim HJ.   +5 more
europepmc   +1 more source

Dysautonomia in Long COVID: Why Sex Differences Matter in Cardiovascular Risk Assessment. [PDF]

Clin Med Res
Mattioli AV.
europepmc   +1 more source

Cardiovascular and autonomic assessment during maximal aerobic exercise in women with functional dysautonomia

, 2015
Functional dysautonomia (FD) is a complex disorder that manifests in both physiological (i.e. , fibromyalgia, irritable bowel syndrome, chronic pain, chronic fatigue, frequent bouts of nausea) and psycho logical (i.e.
Tehrani, Farzad Jalilvand
core  

Autonomic Dysfunction After Guillain-Barré Syndrome: Evidence from Comprehensive Autonomic Testing. [PDF]

J Clin Med
Theologou R, Barkoula T, Ioannou C, Pilavas A, Lambrianides S, Grigoriadis N, Hadjigeorgiou GM, Zis P.   +7 more
europepmc   +1 more source

Correction: Long-term potentiation and neurotransmitters expression and segregation are altered in the Metabolic Syndrome-associated dysautonomia. [PDF]

PLoS One
Elinos D, Veladiz-Gracia F, González-Sierra C, Rubio-Galicia A, Cifuentes F, Morales MA.   +5 more
europepmc   +1 more source

Author Response to "Dysautonomia in Long COVID: Why Sex Differences Matter in Cardiovascular Risk Assessment". [PDF]

Clin Med Res
Tamariz L, Palacio A.
europepmc   +1 more source

Daratumumab Treatment in Severe Anti-NMDAR Encephalitis: Two Case Reports and Literature Review. [PDF]

Neurol Neuroimmunol Neuroinflamm
Ammar N, Uginet M, De Stefano P, Quintard H, Samii K, Seebach JD, Dalmau J, Lalive PH.   +7 more
europepmc   +1 more source

Linking central sensitization to multisystemic manifestations in hypermobile Ehlers-Danlos syndrome. [PDF]

Front Pain Res (Lausanne)
Montemayor Zarazúa AP, Elizondo Solis CV, Ayala García C, Pacheco Estrella DJ, Ilizaliturri Guerra O, Arana Guajardo AC, Purón Gonzalez E, Silva Luna K, Lozano Plata LI, García Pompermayer MR, Garza Elizondo MA.   +10 more
europepmc   +1 more source